← Leaderboards
Thomas J. O'Hare
University Of Utah
$1,289,037
Attributed
$2,578,074
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $555.1K · FY2014–18$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$2,578,074 · 1
By mechanism
R01$2,578,074 · 1
Top collaborators
- Michael W Deininger5 shared
Most similar at University Of Utah
Same institution · by research overlap
- You Han Bae$9,356,304
- Gregory A. Voth$20,545,848
- Kenneth W Spitzer$3,039,983
- David Morris Grant$2,171,357
- William I Higuchi$5,488,090
Others in their field
Top investigators on “Exhibits”
- David R. Weir · University Of Michigan At Ann Arbor$259,685,758
- David W Simpson · University Of Southern California$143,628,960
- Abhik Das · Research Triangle Institute$100,700,289
- Omar N Ghattas · Carnegie Mellon University$94,000,000
- Kelly P Gaither · Purdue University$94,000,000
- Daniel Stanzione · Arizona State University$94,000,000
Research focus
ExhibitsExome SequencingApoptosisEventAffinityBiologyCell KillingCell LineAbl1 GeneChimeric ProteinsChronicChronic Myeloid LeukemiaClinical TrialsComplexCsf1r GeneDasatinibDeep SequencingDesignDiagnosisCellsDimerizationDrug ResistanceDrug TargetingHematopoietic Neoplasms
Grant awards (5)
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia$483,771
R01 · FY2018 · CA · contact PI
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia$518,975
R01 · FY2017 · CA · contact PI
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia$555,104
R01 · FY2016 · CA · contact PI
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia$515,946
R01 · FY2015 · CA · contact PI
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia$504,278
R01 · FY2014 · CA · contact PI